Ranbaxy gets US nod for hypertension drug

Written by Agencies | Mumbai, October 29: | Updated: Oct 29 2007, 21:02pm hrs
India's top drug maker by sales, Ranbaxy Laboratories Ltd, said on Monday it received tentative approval from the US Food and Drug Administration to make and sell valsartan tablets in multiple strengths.

The tablets are used for the treatment of hypertension and heart failure, the company said in a statement. Total annual market sales for valsartan tablets were $1.3 billion, it said.